Article

Cross species association examination of UCN3 and CRHR2 as potential pharmacological targets for antiobesity drugs.

Department of Animal Sciences, Washington State University, Pullman, Washington, United States of America.
PLoS ONE (Impact Factor: 3.53). 01/2006; 1:e80. DOI: 10.1371/journal.pone.0000080
Source: PubMed

ABSTRACT Obesity now constitutes a leading global public health problem. Studies have shown that insulin resistance affiliated with obesity is associated with intramyocellular lipid (IMCL) accumulation. Therefore, identification of genes associated with the phenotype would provide a clear target for pharmaceutical intervention and care for the condition. We hypothesized that urocortin 3 (UCN3) and corticotropin-releasing hormone receptor 2 (CRHR2) are associated with IMCL and subcutaneous fat depth (SFD), because the corticotropin-releasing hormone family of peptides are capable of strong anorectic and thermogenic effects.
We annotated both bovine UCN3 and CRHR2 genes and identified 12 genetic mutations in the former gene and 5 genetic markers in the promoter region of the latter gene. Genotyping of these 17 markers on Wagyu times Limousin F(2) progeny revealed significant associations between promoter polymorphisms and SFD (P = 0.0203-0.0685) and between missense mutations of exon 2 and IMCL (P = 0.0055-0.0369) in the bovine UCN3 gene. The SFD associated promoter SNPs caused a gain/loss of 12 potential transcription regulatory binding sites, while the IMCL associated coding SNPs affected the secondary structure of UCN3 mRNA. However, none of five polymorphisms in CRHR2 gene clearly co-segregated with either trait in the population (P>0.6000).
Because UCN3 is located on human chromosome 10p15.1 where quantitative trait loci for obesity have been reported, our cross species study provides further evidence that it could be proposed as a potential target for developing antiobesity drugs. None of the markers in CRHR2 was associated with obesity-type traits in cattle, which is consistent with findings in human. Therefore, CRHR2 does not lend itself to the development of antiobesity drugs.

0 Bookmarks
 · 
130 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity in humans has increased at an alarming rate over the past two decades and has become one of the leading public health problems worldwide. Studies have revealed a large number of genes/markers that are associated with obesity and/or obesity-related phenotypes, indicating an urgent need to develop a central database for helping the community understand the genetic complexity of obesity. In the present study, we collected a total of 1,736 obesity associated loci and created a freely available obesity database, including 1,515 protein-coding genes and 221 microRNAs (miRNAs) collected from four mammalian species: human, cattle, rat, and mouse. These loci were integrated as orthologs on comparative genomic views in human, cattle, and mouse. The database and genomic views are freely available online at: http://www.integratomics-time.com/fat_deposition. Bioinformatics analyses of the collected data revealed some potential novel obesity related molecular markers which represent focal points for testing more targeted hypotheses and designing experiments for further studies. We believe that this centralized database on obesity and adipogenesis will facilitate development of comparative systems biology approaches to address this important health issue in human and their potential applications in animals.
    Journal of Genomics. 02/2012;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Urotensin 2 (UTS2) and its receptor (UTS2R) are associated with insulin resistance in humans, and many studies have indicated that muscle lipid accumulation is a major contributor to insulin resistance. In beef cattle, marbling is a subjective measurement of intramuscular lipid accumulation. Therefore, the objective of this study was to validate the candidacy of both UTS2 and UTS2R for fat deposition in beef cattle. Both cDNA and genomic DNA sequences of these two genes in cattle were retrieved from public databases and used to design 11 pairs of primers. Direct sequencing of the amplicons identified 5 SNPs in UTS2 and one INDEL and 13 coding SNPs in UTS2R, respectively. However, only one SNP in the promoter of UTS2 and the INDEL in the promoter of UTS2R were chosen for genotyping on ~ 250 Wagyu x Limousin F2 population. Statistical analysis revealed that the former gene was suggestively associated with subcutaneous fat depth (SFD) (P
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: a b s t r a c t Cattle meat provides essential nutrients necessary for a balanced diet and health preservation. Besides nutritional quality, consumers' preferences are related to specific attributes such as tenderness, taste and flavour. The present study characterizes the fatty acid composition of beef, which is an important factor in both nutritional and quality values, in 15 European cattle breeds fed a similar diet and reared in five countries (United Kingdom, Denmark, France, Italy and Spain). The effect of possible slight differences on diet composition which might have occurred between countries were included in the breed effect which confounds country, diet, slaughter house and slaughter day as all individuals of a same breed were managed simultaneously. The wide range of breeds studied and the significant differences on lipid profile described here provide a broad characterization of beef meat, which allows giving a better response to the variety of consumers' preferences. Regarding meat health benefits, the groups that stand out are: the double-muscled animals, which displayed lower total fat, lower proportion of saturated (SFA) and monounsaturated (MUFA) fatty acids, and a higher proportion of polyunsaturated (PUFA) fatty acids; and Limousin and Charolais breeds with a signifi-cantly higher conversion of 18:3n-3 PUFA to the long chain 22:6n-3 PUFA.
    Livestock Science 02/2014; 160:1-11. · 1.25 Impact Factor

Full-text (2 Sources)

Download
48 Downloads
Available from
Jun 1, 2014